Example: confidence
PRODUCT MONOGRAPH INCLUDING PATIENT …
BESPONSATM Product Monograph Page 1 of 43 PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION PrBESPONSATM inotuzumab ozogamicin for injection Lyophilized ...
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
PRODUCT MONOGRAPH INCLUDING PATIENT …
www.pfizer.caINCLUDING PATIENT MEDICATION INFORMATION COMIRNATY COVID-19 Vaccine, mRNA Suspensionfor Intramuscular Injection Multiple Dose Vial For 12 Years of Age and Older(after dilution each vial contains 6†doses of 0.3 mL) For Age 5 Years to <12 Years(after dilution each vial contains 10* doses of 0.2 mL) Active Immunizing Agent BioNTech Manufacturing ...
PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION …
www.pfizer.caPatients with severe infections such as sepsis, abscesses, tuberculosis and opportunistic ... This evaluation should include a detailed medical ... and/or current immunosuppressive therapy. Appropriate screening tests, i.e. tuberculin skin test and chest x-ray (if indicated), should be performed in all patients. ...
PRODUCT MONOGRAPH - Pfizer Canada
www.pfizer.caPrevnar® 13 (Pneumococcal 13-valent Conjugate Vaccine) Product Monograph Page 7of 61 3. Adults 18Years and Older Safety was assessed in 7 clinical studies including 91,593 adults ranging in ages from 18 to 101 years. Prevnar 13 was administered to 48,806 adults; 2,616 adults were aged 50-64 years and 45,291 adults were 65 years and older.
DEPO-TESTOSTERONE - Pfizer Canada
www.pfizer.caTestosterone may cause fetal harm. Testosterone exposure during pregnancy has been reported to be associated with fetal abnormalities. Testosterone is known to cause virilization of the external genitalia of the female fetus when administrated to pregnant women. Nursing Women: DEPO-TESTOSTERONE should not be used in nursing women.
Related documents
PRODUCT MONOGRAPH INCLUDING PATIENT …
ca.eisai.comLENVIMATM Product Monograph Page 1 of 52. PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION . PrLENVIMA. Lenvatinib capsules . 4mg and 10mg Lenvatinib (as lenvatinib mesylate) Multiple Receptor Tyrosine Kinase Inhibitor
PRODUCT MONOGRAPH INCLUDING PATIENT …
ca.gsk.comPage 1 of 40 PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION PrNUCALA Mepolizumab for Injection 100 mg/mL lyophilized powder for subcutaneous injection
PRODUCT MONOGRAPH INCLUDING PATIENT …
ca.gsk.comPage 1 of 49 PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION PrTRELEGY ELLIPTA fluticasone furoate/umeclidinium (as bromide)/vilanterol (as trifenatate), dry powder for oral
PRODUCT MONOGRAPH INCLUDING PATIENT …
labeling.cslbehring.caPage 1 of 24 . PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION . HAEGARDA™. C1 Esterase Inhibitor Subcutaneous (Human) Lyophilised powder 2000 IU/vial, reconstituted with 4 mL of diluent
PRODUCT MONOGRAPH INCLUDING PATIENT …
pp.jazzpharma.comPRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION C XYREM® (sodium oxybate) Oral solution at 500 mg/mL CNS Depressant Jazz Pharmaceuticals Ireland Limited
PRODUCT MONOGRAPH INCLUDING PATIENT …
products.sanofi.caADLYXINE - Product Monograph Page 1 of 79. PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION . Pr ADLYXINE™ . lixisenatide injection . 0.05 mg per mL (10 μg/dose)
PRODUCT MONOGRAPH INCLUDING PATIENT …
products.sanofi.caPage 1 of 64. PRODUCT MONOGRAPH. INCLUDING PATIENT MEDICATION INFORMATION . PrPRALUENT®. alirocumab . solution for subcutaneous injection . 75 mg/mL and 150 mg/mL
PRODUCT MONOGRAPH INCLUDING PATIENT …
purdue.caFOQUEST™ (methylphenidate hydrochloride CR capsules) Page 1 of 37 . PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION . FOQUEST™ methylphenidate hydrochloride
INCLUDING PATIENT MEDICATION …
purdue.caDilaudid® (hydromorphone HCl) Page 1 of 36. PRESCRIBING INFORMATION . INCLUDING PATIENT MEDICATION INFORMATION . NDILAUDID® (HYDROmorphone* hydrochloride) 1 mg, 2 mg, 4 mg and 8 mg Tablets . 2 mg/mL Sterile Solution for Injection
INCLUDING PATIENT MEDICATION …
hepcbc.cacirrhosis including 1035 patients who received EPCLUSA for 12 weeks. The proportion of patients who permanently discontinued treatment due …
Related search queries
PRODUCT MONOGRAPH INCLUDING PATIENT, PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION, PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION, INCLUDING PATIENT, INCLUDING PATIENT MEDICATION INFORMATION, PRODUCT MONOGRAPH. INCLUDING PATIENT MEDICATION INFORMATION, INCLUDING PATIENT MEDICATION, INFORMATION, Including